Stock-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2022

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Summary of Stock Plan Activity

Summaries of the Company’s 2018 Stock Plan activity for the three months ended March 31, 2022 is presented below.

	Options Outstanding
	Number of Options			Weighted- Average Exercise Price ($ per share)		Weighted Average Remaining Contractual Life (years)		Aggregate Intrinsic Value
December 31, 2021		10,457		$	0.51		7.96	$	-
Granted		175		$	9.58
Exercised		(131	)	$	0.47
Cancelled and forfeited		(326	)	$	0.47
March 31, 2022		10,175		$	0.66		7.75	$	-
Vested options as of March 31, 2022		8,022		$	0.49		7.53	$	-

Summary of Restricted Stock Units Activity

The following table summarizes activity related to the RSUs:

	Restricted Stock Units
	Number of Restricted Stock Units			Weighted Average Grant Date Fair Value (per share)
December 31, 2021		7,671		$	4.98
Granted		1,510		$	7.54
Cancelled		(136	)	$	4.82
March 31, 2022		9,045		$	5.29

Summary of Fair value of Stock Option Grants

The fair value of stock option grants is estimated by the Company on the date of grant using the Black Scholes-Merton option pricing model with the following weighted-average assumptions for the three months ended March 31, 2022.

	March 31, 2022
Risk free interest		1.47	%
Dividend yield		0.00	%
Expected volatility		58.80	%
Expected life (years)		6.08

Summary of Stock-based Compensation Expense

The Company recorded stock-based compensation expense as follows.

	For the three months ended March 31,
	2022		2021
Research and development	$	881	$	55
Sales and marketing		539		16
General and administrative		2,103		356
Total	$	3,523	$	427